Skip to Main Content

Paper Details

Personalized Decision Making in Early Stage Breast Cancer: Applying Clinical Prediction Models for Anthracycline Cardiotoxicity and Breast Cancer Mortality Demonstrates Substantial Heterogeneity of Benefit-Harm Trade-off.
Clin Breast Cancer
21
2019
Author NameAffiliation
Robin RuthazerThe Predictive Analytics and Comparative Effectiveness Center Institute for Clinical Research and Health Policy Studies, Tufts Medical Center
  • 1 - 1

Datasets

Release 1.2